RxDoctor Payments Data

Joanna van

Family Medicine · Colton, CANPI 1639250194

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $2,640 of the $3,928 with a category attached, or 67.2%. Eli Lilly accounts for 98.5% of it on its own, with 1 other manufacturer making up the rest. Reporting peaked in 2021 at $3,871 and has fallen 99.0% since, to $40 in 2022. Among family medicine clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$3,928in general payments, 2019–2025

Across 7 payments — averaging $561.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Eli Lilly$4K
  • Sanofi-aventis U.S. LLC$58
$8,716,612in research payments, 2019–2025

Across 1,931 payments — averaging $4514.04 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Eli Lilly$6.5M
  • Sanofi US Services Inc.$999K
  • Pfizer$825K
  • Novo Nordisk AS$217K
  • Genentech, Inc.$164K
  • Merck$169

What the payments were for

  • Speaking & faculty fees$2,64067%
  • Travel & lodging$1,23131%
  • Food & beverage$581%

General payments by program year

19
21
22

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Eli Lilly4$3,871
Sanofi-aventis U.S. LLC3$58

How this compares

$3,928 in reported general payments places this provider in the 90th percentile of 10,533 family medicine providers in California.

See all family medicine providers in California

Other family medicine in Colton

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →